High doses of fluphenazine enanthate in schizophrenia: A CONTROLLED STUDY
- 1 May 1978
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 57 (5) , 405-414
- https://doi.org/10.1111/j.1600-0447.1978.tb06909.x
Abstract
Treatment with fluphenazine enanthate in higher doses than normal (10-20 times higher) may give reduction in psychopathology beyond what can be obtained with normal doses. In 4 patients the symptom reduction on high doses was pronounced. The high fluphenazine plasma levels demonstrated did not increase extrapyramidal and general side effects. Certain non-responding patients may need a higher plasma level of a neuroleptic drug than the average patient.Keywords
This publication has 9 references indexed in Scilit:
- A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALEActa Psychiatrica Scandinavica, 1978
- Plasma levels and clinical response to megadose fluphenazine enanthate in three manic psychoticsNordisk Psykiatrisk Tidsskrift, 1978
- Very High Dose Fluphenazine DecanoateArchives of General Psychiatry, 1976
- The long-term use of high doses of fluphenazine enanthate and fluphenazine decanoateComprehensive Psychiatry, 1975
- CLINICAL EXPERIENCE WITH DEPOT NEUROLEPTICSActa Psychiatrica Scandinavica, 1973
- INTRAMUSCULAR LONG-ACTING FLUPHENAZINE IN THE TREATMENT OF SCHIZOPHRENIAActa Psychiatrica Scandinavica, 1970
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970
- THE MEASUREMENT OF BEHAVIOUR IN CHRONIC SCHIZOPHRENIAActa Psychiatrica Scandinavica, 1960